Optimal waist circumference for prediction of metabolic syndrome in Young Korean women with polycystic ovary syndrome

Obesity

Volumn 18, Issue 3, 2010, Pages 593-597

  Oh, Jee Young ^a   Sung, Yeon Ah ^a   Lee, Hye Jin ^a   Oh, Ji Young ^a   Chung, Hye Won ^a   Park, Hyesook ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; FEMALE; HUMAN; INTRAABDOMINAL FAT; KOREA; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; WAIST CIRCUMFERENCE;

ADULT; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KOREA; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 77249146857     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.297     Document Type: Article

References (32)

1. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-419.
2. Asunción M, Calvo RM, San Millán JL et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
3. Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 2007;18:266-272.
4. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:302-312.
5. Shaw LJ, Bairey Merz CN, Azziz R et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008;93:1276-1284.
6. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002;26:883-896.
7. Cibula D. Is insulin resistance an essential component of PCOS? The influence of confounding factors. Hum Reprod 2004;19:757-759.
8. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-1174.
9. National Cholesterol, Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
10. Examination Committee of Criteria for "Obesity Disease" in Japan: Japan Society for the study of Obesity. new criteria for "Obesity Disease" in Japan. Circ J 2002;66:987-992.
11. WHO Western Pacific Region, IASO and IOTF: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limit: Sydney, Australia 2000.
12. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome\a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
13. Araneta MR, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women: a high-risk nonobese population. Diabetes Care 2002;25:494-499.
14. Fujimoto WY, Bergstrom RW, Boyko EJ et al. Type 2 diabetes and the metabolic syndrome in Japanese Americans. Diabetes Res Clin Pract 2000;50 Suppl 2:S73-S76.
15. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-386.
16. Unwin N, Harland J, White M et al. Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health 1997;51:160-166.
17. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
18. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 2006;113:1203-1209.
19. Bao Y, Lu J, Wang C et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008;201:378-384.
20. Kim JA, Choi CJ, Yum KS. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006;21:1048-1053.
21. Hayashi T, Boyko EJ, McNeely MJ et al. Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome. Diabetes Care 2007;30:120-127. (Pubitemid 46052509)
22. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metab Clin Exp 2003;52:908-915.
23. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935.
24. Dokras A, Bochner M, Hollinrake E et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106: 131-137.
25. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005;20:2409-2413.
26. Park HR, Choi YJ, Lee H-J et al. The metabolic syndrome in young Korean women with polycystic ovary syndrome. Diabetes Res Clin Pract 2007;77S:243-246.
27. Rotterdam ESHRE/ASRM-sponsored PCOS consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
28. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
29. Oka R, Kobayashi J, Yagi K et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008;79:474-481.
30. Despres J P, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease. Nutr Res Rev 1993;6:137-159.
31. Azziz R, Ehrmann D, Legro RS et al. PCOS/Troglitazone Study Group. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001;86:1626-1632.
32. Park HR, Choi YJ, Lee H-J et al. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome. Diabetes Res Clin Pract 2007;77S:233-237.